New drug combo aims to slow advanced breast cancer
NCT ID NCT04920708
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding the experimental drug ipatasertib to standard hormone therapy and targeted drugs can help people with a certain type of advanced breast cancer (ER+/HER2-) live longer without their cancer growing. It includes 57 participants whose cancer did not respond well to initial treatment. The goal is to see if the new combination works better than the standard treatment alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrookes Hospital
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
-
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
-
Imperial College University Hospitals NHS Trust
London, W2 1NY, United Kingdom
-
Mount Vernon Cancer Centre
London, Surrey, HA6 2RN, United Kingdom
-
Nottingham City Hospital
Nottingham, United Kingdom
-
Oxford University Hospitals
Oxford, OX3 7LE, United Kingdom
-
Royal Cornwall Hospital
Truro, Cornwall, TR1 3LQ, United Kingdom
-
Royal Free Hospital
London, NW3 2QC, United Kingdom
-
Royal Marsden NHS Foundation Trust
London, SW3 6JJ, United Kingdom
-
The Christie NHS Foundation Trust
Manchester, M20 4BX, United Kingdom
-
University College London Hospital
London, United Kingdom
-
Velindre Cancer Centre
Cardiff, Wales, CF14 2TL, United Kingdom
-
Western General Hospital
Edinburgh, EH4 2XU, United Kingdom